Daniel Alvarez

@daninthenet.bsky.social

Senior Drug Designer | #AI Computational Medicinal Chemist | #medchem + #compchem | Also into #pottery and #oilpainting

For all the gains AI affords in compound design and discovery, experimental validation still remains a bottleneck. But we're making that part easy for the cancer target TBXT with a suite of biophysical, in vitro and in vivo assay capabilities—plus prizes for potent binders: tbxtchallenge.org

TBXT CHALLENGE – Make history in drug discovery

Make history in drug discovery

tbxtchallenge.org

Chemistry World@chemistryworld.com · 2y ago

Will AI revolutionise drug design and discovery? Not the parts that count, says @dereklowe.bsky.social. Biology doesn’t care whether a drug was designed by a human or an algorithm, and there is no AI yet that can competently predict clinical trial outcomes. www.chemistryworld.com/opinion/robo...

And now o3-mini has also been released… and my first test is quite successful. I am prompting it to build a python interface for REINVENT4. So far o3-mini has performed best against deepseek and chat-gpt4. Best by far!

How do you imagine the new reasoning LLM models will impact drug design? I’m starting to realize how important Agents will be in near future. They might become the new interface for everything we do. It is overwhelming to imagine all the possibilities.

Hi there! I’m moving in. I need to rebuild the network I had on Twitter/X. I mainly use this to keep in touch with folks ans science in drug discovery in general. Structure based drug design in particular. Some support would be great! 🙌